Needham, MA, United States of America

Karen S Aboody

This inventor holds 10 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Beckman Research Institute, City of Hope, Children's Medical Center Corporation, Northeastern Ohio University. Active years: 2007-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karen S Aboody. Retrieved from https://idiyas.com/inventor/karen-s-aboody

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 80.0



Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 36(Granted Patents)


Location History:

  • Needham, MA (US) (2007 - 2008)
  • Duarte, CA (US) (2019)
  • Arcadia, CA (US) (2010 - 2023)

Company Filing History:


Years Active: 2007-2025

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Journey of Karen S Aboody in Cancer Research

Introduction

Karen S Aboody, based in Needham, MA, is a pioneering inventor with a remarkable portfolio comprising nine patents. Her innovative contributions primarily focus on cancer treatment solutions, integrating advanced technologies such as nanoparticles and neural stem cells. Aboody's work exemplifies the intersection of biotechnology and invention, driving forward the frontiers of medical science.

Latest Patents

Among her most significant inventions is the patent for a nanoparticle-cell construct utilizing a platinum anti-cancer agent. This groundbreaking disclosure includes compositions featuring cell-nanoparticle constructs and drug-loaded nanoparticles, paving new avenues for cancer treatment. One notable aspect of this invention is the use of unmodified cisplatin molecules encapsulated by silica nanoparticles, targeting effective cancer therapies.

Another pivotal patent is the development of neural stem cell-mediated cancer treatment. This method combines neural stem cells (NSCs) with oncolytic viruses to enhance therapeutic efficacy. Aboody’s innovative approach entails administering pharmaceutical compositions that incorporate NSCs and oncolytic viruses, offering promising treatment options for various cancer types, including but not limited to brain, breast, and lung cancers.

Career Highlights

Throughout her career, Aboody has made significant impacts at various research institutions. Notably, she has worked with City of Hope and Children’s Medical Center Corporation, contributing her expertise in cancer biology and treatment development. Her patents reflect a deep understanding of collaborative research and translational medicine, allowing her inventions to flourish in clinical settings.

Collaborations

Karen S Aboody has had the privilege of collaborating with esteemed colleagues in the field. Notable collaborators include Evan Y Snyder and Xandra O Breakefield. These partnerships have fostered a dynamic research environment, further enhancing the innovative capabilities of her projects.

Conclusion

Karen S Aboody stands as a testament to the power of innovation in the realm of cancer treatment. Her nine patents underscore her commitment to advancing medical science and providing new hope for patients combating cancer. With each invention, Aboody not only contributes to the scientific community but also inspires future generations of inventors and researchers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…